Resource utilization and healthcare costs for acute coronary syndrome patients with and without diabetes mellitus

References

• Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction — executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, American College of Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2007;50:652-726
   Google Scholar
• Kolansky DM. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am J Manag Care 2009;15:S36-41
   PubMedGoogle Scholar
• Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:e21-181
   PubMed Web of Science ®Google Scholar
• Etemad LR, McCollam PL. Total first-year costs of acute coronary syndrome in a managed care setting. J Manag Care Pharm 2005;11:300-306
   PubMedGoogle Scholar
• McCollam P, Etemad L. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularisation. J Invasive Cardiol 2005;17:307-311
   PubMedGoogle Scholar
• Menzin J, Wygant G, Hauch O, et al. One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database. Curr Med Res Opin 2008;24:461-468
   PubMed Web of Science ®Google Scholar
• Shetty S, Halpern R, McCollam PL. Cost of care for new versus recurrent acute coronary syndrome patients. J Med Econ 2008;11:81-99
   PubMedGoogle Scholar
• Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359:2140-2144
   PubMed Web of Science ®Google Scholar
• Franklin K, Goldberg RJ, Spencer F, et al. Implications of diabetes in patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med 2004;164:1457-1463
   PubMed Web of Science ®Google Scholar
• Tenerz A, Lonnberg I, Berne G, et al. Myocardial infarction and prevalence of diabetes Mellitus: Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J 2001;22:1102-1110
   PubMed Web of Science ®Google Scholar
• Gandhi GY, Roger VL, Bailey KR, et al. Temporal trends in prevalence of diabetes mellitus in a population-based cohort of incident myocardial infarction and impact of diabetes on survival. Mayo Clin Proc 2006;81:1034-1040
   Google Scholar
• Benjamin SM, Geiss LS, Pan L, et al. Self-reported heart disease and stroke among adults with and without diabetes – United States, 1999–2001. MMWR Weekly 2003;52:1065-1070
   PubMedGoogle Scholar
• Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organisation to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000;102:1014-1019
   PubMed Web of Science ®Google Scholar
• Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002;90:358-363
   PubMed Web of Science ®Google Scholar
• McGuire DK, Emanuelsson H, Granger CB, et al. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators. Eur Heart J 2000;21:1750-1758
   PubMed Web of Science ®Google Scholar
• Hasdai D, Behar S, Boyko V, et al. Treatment modalities of diabetes mellitus and outcomes of acute coronary syndromes. Coron Artery Dis 2004;15:129-135
   Google Scholar
• Fox CS, Coady S, Sorlie PD, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham heart study. Circulation 2007;115:1544-1550
   PubMed Web of Science ®Google Scholar
• Hasin T, Hochadel M, Gitt AK, et al. Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus. Am J Cardiol 2009;103:772-778
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhu B, Anderson J, et al. Real-world practice patterns in acute coronary syndrome patients with and without diabetes mellitus. Manuscript submitted for publication, 2010
   Google Scholar
• Donahoe SM, Stewart GC, McCabe CH, et al. Diabetes and mortality following acute coronary syndromes. JAMA 2007;298:765-775
   PubMed Web of Science ®Google Scholar
• Etemad LR. McCollam PL. Predictors of high-cost managed care patients with acute coronary syndrome. Curr Med Res Opin 2005;21:1977-1984
   PubMed Web of Science ®Google Scholar
• Bramkamp M, Radovanovic D, Erne P, et al. Determinants of costs and the length of stay in acute coronary syndromes: a real life analysis of more than 10,000 patients. Cardiovasc Drugs Ther 2007;21:389-398
   PubMed Web of Science ®Google Scholar
• Novo G, Scordato F, Cerruto G, et al. In-hospital stay of patient with acute coronary syndrome with or without diabetes mellitus. Minerva Cardioangiologica 2009;57:159-164
   PubMedGoogle Scholar
• Epstein DM, Sculpher MJ, Clayton TC, et al. Costs of an early intervention versus a conservative strategy in acute coronary syndrome. Int J Cardiol 2007;127:240–246
   Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383
   PubMedGoogle Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619
   PubMed Web of Science ®Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-1139
   PubMed Web of Science ®Google Scholar
• Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55
   Web of Science ®Google Scholar
• Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on a propensity score. J Am Stat Assoc 1984;79:516-524
   Google Scholar
• Faries D, Leon A, Haro J, et al. Analysis of Observational Health Care Data Using SAS. 2010. SAS institute
   Google Scholar
• Nichols GA, Brown JB. The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes. Diabetes Care 2002;25:482-486
   PubMed Web of Science ®Google Scholar
• Joyce AT, Iacoviello JM, Nag S, et al. End-stage renal disease–associated managed care costs among patients with and without diabetes. Diabetes Care 2004;27:2829-2835
   PubMed Web of Science ®Google Scholar
• Diehr P, Yanez D, Ash A, et al. Methods for analyzing health care utilisation and costs. Annu Rev Public Health 1999;20:125-144
   PubMed Web of Science ®Google Scholar
• Feise RJ. Do multiple outcome measures require p-value adjustment? BMC Med Res Methodol 2002;2:2-8
   Google Scholar